Prime Minister of Ukraine Volodymyr Groysman cautions pharmaceutical companies in Ukraine against creating artificial drug shortages and fixing inflated prices following the Government’s decisions on deregulation of the pharmaceutical market. The Head of Government said during a meeting with representatives of pharmaceutical companies on Tuesday.
"I will do my utmost to seek the solution to this issue – to ensure that in Ukraine there is fair pricing for medicines, relevant quality, so that we could conduct the procurement of medicines at fair, competitive prices, that we could deliver timely these drugs to the hospitals. All government agencies will be focused on achievement of this goal," promised Volodymyr Groysman.
The Head of Government called on representatives of pharmaceutical companies to engage in partnership dialogue, "in which the people - the Ukrainian citizens - will feel these changes in their own lives, their own wallet, they will have to spend less. It is our common task," he said.
"For us it is very important to achieve the final goal: price - quality should be acceptable for the Ukrainian citizens. For this we will fight, and we have no other choice but to win," emphasized the PM.
The Prime Minister noted that since the beginning of its work the Government had determined as a priority the solution to the problem of availability of medicines in Ukraine and improving their quality.
Speaking about the system of pricing for drugs, the Head of Government noted that many examples show that drug prices in Ukraine are not always fair, sometimes inflated.
In this direction the Government has made several steps, said the Prime Minister. Namely, registration of drugs has been simplified in Ukraine for those [medicines] produced and consumed in the EU, the U.S.A., Canada, Japan, Australia, and Switzerland.
With the aim to create a system preventing one to raise prices on medicines in Ukraine, the Government introduced reference pricing. The system will be launched on 1 January 2017.
Moreover, recently the Government has adopted a decision on the introduction of a mechanism for reimbursement for drugs from cardiovascular disease, diabetes type II and bronchial asthma starting from 1 April 2017. For these purposes there have been planned the sum worth UAH 500 million.
The Government is committed to carrying out public procurement of medicines through international organizations. For the next year it was budgeted UAH 5.9 billion in this area.
"If we take the system as a single whole, in 2017 we have to ensure good quality medicines in Ukraine, appropriate prices for these drugs, to protect those chronic patients who can not afford themselves to buy the medication and to compensate for their costs from the State budget, and the fourth position is a matter of procurement of medicines. In fact, these are the four specific directions which will allow us for the first time to make some serious headway," said the Prime Minister about the initiatives of the Government.
Volodymyr Groysman noted that the Government's decisions "aren’t widely appreaciate and not everyone is ready to accept the fact that the time has come when everything will be transparent, without any corruption factors, manifestations on the part of the authorities".
In this regard the Prime Minister called on the representatives of pharmaceutical companies to develop understanding, to act responsibly in accepting the Government’s decisions and to facilitate their immediate implementation.